BioCryst Signs European License for Navenibart in Angioedema
04 May 2026 //
GLOBENEWSWIRE
Lupin Signs Licensing Deal With Neopharmed For Plasil
18 Dec 2025 //
PRESS RELEASE
BioCryst Sells European ORLADEYO Business to Neopharmed Gentili
27 Jun 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support